Trial
NCT04410523
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Asthma
Intervention
CSJ117
Why stopped
Sponsor Desicion
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-20